STMP Group | Half-dose PDT Group | P value | |
---|---|---|---|
Variables | (n = 18) | (n = 21) | |
Complete absorption of | |||
macular SRF at month 12, | |||
(n) | 15(83.3%) | 19(90.5%) | 0.647 |
Change in BCVA at month 12, | |||
(n), (ETDRS) | |||
Gained ≥ 15 letters | 6 (33.3%) | 8(38.1%) | 0.757 |
Gained ≥ 5 letters | 15(83.3%) | 19(90.5%) | |
No change | 3(16.7%) | 2(9.5%) | 0.506 |
Lost ≥ 5 letters | 0 | 0 | |
Number of treatment over | |||
the 12-month period, (n) | |||
1 | 11 | 17 | |
2 | 5 | 3 | |
3 | 0 | 0 | |
4 | 2 | 1 | 0.174 |